相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Dengue-1 Envelope Protein Domain III along with PELC and CpG Oligodeoxynucleotides Synergistically Enhances Immune Responses
Chen-Yi Chiang et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses
Chen-Yi Chiang et al.
PLOS ONE (2011)
CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2010)
Inhibition of the Type I Interferon Response in Human Dendritic Cells by Dengue Virus Infection Requires a Catalytically Active NS2B3 Complex
Juan R. Rodriguez-Madoz et al.
JOURNAL OF VIROLOGY (2010)
Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2
Soila Sukupolvi-Petty et al.
JOURNAL OF VIROLOGY (2010)
Dengue: a continuing global threat
Maria G. Guzman et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Development of a recombinant tetravalent dengue virus vaccine: Innmunogenicity and efficacy studies in mice and monkeys
David E. Clements et al.
VACCINE (2010)
NS5 of Dengue Virus Mediates STAT2 Binding and Degradation
Joseph Ashour et al.
JOURNAL OF VIROLOGY (2009)
Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation
Hsien-Jen Cheng et al.
MOLECULAR IMMUNOLOGY (2009)
A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity
Chih-Hsiang Leng et al.
MICROBES AND INFECTION (2009)
A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design
Hsin-Wei Chen et al.
VACCINE (2009)
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
W. M. P. B. Wahala et al.
VIROLOGY (2009)
Global Spread and Persistence of Dengue
Jennifer L. Kyle et al.
ANNUAL REVIEW OF MICROBIOLOGY (2008)
Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques
Chien-Hsiung Pan et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus
Kanakatte Raviprakash et al.
JOURNAL OF VIROLOGY (2008)
Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II
Chih-Yun Lai et al.
JOURNAL OF VIROLOGY (2008)
The mannose receptor mediates dengue virus infection of macrophages
Joanna L. Miller et al.
PLOS PATHOGENS (2008)
An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice
Laura J. White et al.
JOURNAL OF VIROLOGY (2007)
CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system
Elizabeth M. Sitati et al.
JOURNAL OF VIROLOGY (2006)
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein Vaccines in rhesus macaques
Monika Simmons et al.
JOURNAL OF VIROLOGY (2006)
A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates
L Hermida et al.
VACCINE (2006)
Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice
E Konishi et al.
VACCINE (2006)
The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection
Kao-Jean Huang et al.
JOURNAL OF IMMUNOLOGY (2006)
Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles
CH Pan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein
J Mota et al.
VACCINE (2005)
Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys
JE Blaney et al.
JOURNAL OF VIROLOGY (2005)
A structural perspective of the Flavivirus life cycle
S Mukhopadhyay et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Structure of the dengue virus envelope protein after membrane fusion
Y Modis et al.
NATURE (2004)
Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice
SF Wu et al.
VACCINE (2003)
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells
B Tassaneetrithep et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3 ' untranslated region is highly attenuated and immunogenic in monkeys
SS Whitehead et al.
JOURNAL OF VIROLOGY (2003)
Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine:: Requirement for antibody but not CD8+ cytotoxic T-cell responses
CH Pan et al.
JOURNAL OF VIROLOGY (2001)
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2000)
分享论文
